TOKYO, Nov 3 (Bernama-BUSINESS WIRE) — CureApp, Inc. (Head Office: Chuo-ku, Tokyo; CEO: Kohta Satake) announces the start of insurance coverage for its CureApp HT Hypertension Adjunctive Treatment App (hereafter, CureApp HT), a DTx*¹ solution treating hypertension, in Japan from September 1, 2022. Looking ahead, the app will be prescribed and provided to patients with hypertension as a health insurance treatment at medical institutions.
- November 3, 2022
0
279
Less than a minute
You can share this post!
administrator
Related Articles
Pluxee Fiscal 2024 Results
- November 1, 2024
XPENG Now On Fortune China’s “Tech 50” and…
- November 1, 2024
NatureAlpha Launches New Geo-AI Platform As TNFD Adoption…
- November 1, 2024